抗宏化物耐药的 Mycoplasma pneumoniae 是儿童支气管粘液塞形成的独立危险因素
Xie Chunlian1, Zhou Lili1, Zhang Libin2
1Department of Pediatric, Women and Children'S Hospital, Ganzhou, 341000, Jiangxi, China.
European journal of pediatrics
|March 24, 2025
概括
抗宏化物耐药的Mycoplasma pneumoniae (MRMP) 是儿童支气管粘液塞的重要危险因素. 这些插头与儿科患者的发烧和更长的住院时间有关.
科学领域:
- 儿科呼吸系统医学 儿科呼吸系统医学
- 传染性疾病 传染性疾病
- 微生物学 微生物学
背景情况:
- 菌性肺炎 (MP) 感染可能导致支气管粘液塞的形成.
- 抗宏化物MP (MRMP) 已被确定为这些插头的潜在风险因素.
研究的目的:
- 为了研究儿童支气管粘液塞形成的特征.
- 确定与支气管粘液塞相关的危险因素,特别关注Mycoplasma pneumoniae.
主要方法:
- 分析了一组578名接受支气管支气管洗的儿童.
- 用下一代测序和聚合酶链反应来检测MP和宏类耐药基因.
- 统计分析,包括后勤回归,确定了独立的风险因素.
主要成果:
- 带有粘液塞的孩子比较年长,住院时间更长,发烧率更高,并发症更多,荷尔蒙使用增加.
- 在粘液塞组中,MP和化物耐药性的检测率明显高于粘液塞组.
- 抗宏胺的MP (MRMP) 被确定为支气管粘液塞形成的独立风险因素.
结论:
- 支气管粘液塞在患有MP感染的儿童中很常见,并与发烧和长时间住院有关.
- 抗宏化物耐药的Mycoplasma pneumoniae被证实是小儿科患者支气管粘液塞发展的独立风险因素.
更多相关视频
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
15.0K
06:04Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
2.3K
相关概念视频
Pneumonia I: Introduction
201
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
201
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
205
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
205
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
